Montpellier-based dental robotics startup Lupin Dental closes €15 million Series A round
Lupin Dental, a Montpellier-based early-stage robotics company focused on developing innovative dental technologies, has announced the close of its €15 million Series A financing round. The round was led by Fynveur with a €10 million investment, with participation from its existing shareholders and private investors. The financing was further complemented by a loan from Bpifrance. […] The post…
Montpellier-based dental robotics startup Lupin Dental has successfully closed a €15 million Series A funding round, marking a significant milestone in the company's mission to revolutionize dental care through innovative technology. The Series A round was led by venture capital firm Fynveur, which provided €10 million in investment. Additional support came from existing shareholders and private investors, as well as a loan from Bpifrance, the French government's investment agency.
Fynveur, in collaboration with its advisor Invus, will work closely with Lupin Dental to offer strategic guidance and support for the company's operations. Invus will also join Lupin Dental's board of directors. Co-founders Dr. Galip Gürel and Dr. Stefen Koubi expressed their gratitude, stating that the €15 million Series A round validates the company's vision and enables them to accelerate their progress.
Founded in 2019, Lupin Dental is a robotics firm that develops cutting-edge solutions aimed at enhancing procedural precision, streamlining clinical workflows, and improving patient outcomes. The company's flagship product, the Lupin® Robotic System, is a supervised automated robotic platform designed for minimally invasive tooth preparation procedures for aesthetic veneers.
The system comprises a software suite for designing a patient's ideal smile and generating the necessary tooth preparation treatment plan, which the robotic workstation then executes to ensure accurate tooth preparation.
The Lupin® Robotic System received UKCA certification in June 2026, allowing its commercialization in Great Britain, following earlier regulatory approvals in India. However, the system remains unapproved for clinical use in the United States and the European Union. Earlier this year, Lupin Dental announced the appointment of Michel Mayer as chairman of the board and Philippe Veran as a new board member.
Mayer, a former CEO of Freescale Semiconductor, and Veran, a prominent entrepreneur in the dental technology industry, bring valuable expertise to the company's leadership team.
Lupin Dental plans to expand its partnerships with leading academic and medical institutions, as well as dental professionals, including individual dentists and Dental Service Organisations (DSOs). These collaborations will help promote the widespread adoption of the company's robotic technology.
Written by urgent.news from EU-Startups's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
